跳至主要内容
临床试验/CTRI/2021/02/031023
CTRI/2021/02/031023尚未招募不适用

Comparison of Laparoscopic Pectopexy with the standard Laparoscopic Sacropexy for Apical Prolapse: An exploratory randomized controlled trial.

All India Institute Of Medical Sciences Rishikesh1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2021年5月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
56
试验地点
1
主要终点
Average placement of mesh time

研究概览

简要总结

Sacrocolpopexy isconsidered to be the gold standard surgical treatment of vaginal vaultprolapse. Abdominal and laparoscopic approaches to sacrocolpopexy are feasible,but the laparoscopic sacrocolpopexy obviates the need of large abdominalincision, and associated with minimal tissue handling, less blood loss, lesspostoperative morbidity, less pain, shorter hospital stay. Laparoscopicsacrocolpopexy is preferred than open sacrocolpopexy for apical vaginal defectin hands of expertise.

The laparoscopicpectopexy is a newer alternative of sacropexy. It was first described in 2010by Noe KG et al , especially for obese women. In laparoscopic pectopexy,mesh is fixed at bilateral ilio-pectineal ligament and the apex of vaginalvault or anterior cervical wall. The mess follows the natural anatomicalstructure (round and broad ligament) to maintain the physiological axis withoutcrossing ureter or bowel; therefore, pelvic outlet does not shrink and it fixesthe weakness using lateral parts of the ilio-pectineal ligaments on both sides.In addition, the hypogastric vessels are also a safe distance from any danger.

The aim of the present study is to compare laparoscopicpectopexy with the standard laparoscopic sacropexy in women with symptomaticapical prolapse (POP-Q >stage II).

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
Female

入选标准

  • 1.Women with symptomatic apical prolapse (uterovaginal prolapse or vaginal vault prolapse) of stage 2 or greater according to the Pelvic Organ Prolapse Quantification (POP-Q) system.
  • 2.Women who agree to participate in the trial and to comply with the protocol and give their written consent for the same.
  • 3.Patients who are able to communicate by telephone and answer questions.
  • 4.Adequate cardio respiratory, renal and liver functions and who will be fit to undergo surgery.

排除标准

  • Prior surgeries for vaginal prolapse correction
  • Active pelvic inflammatory disease
  • Current pregnancy
  • Any contraindications against one of the surgical methods applied in the study, hence making the randomization impossible (e.g. previously identified or strongly suspected massive adhesions between sigmoid colon and presacral peritoneum.
  • History of premalignant or malignant diseases of uterus, cervix or adnexa
  • Any contraindication for laparoscopic surgery
  • Patient unfit for anaesthesia 8.

结局指标

主要结局

Average placement of mesh time

时间窗: 1 year 6 month

次要结局

  • operation time, blood loss, occurrence of major complications.(Hemoglobin decline, Pain (VAS score), duration of hospital stay, onset of bowel movements, episodes of constipation, urinary retention or urgency, de novo urinary incontinence (urge or stress urinary incontinence), urinary tract infections, occurrence of de novo anterior and lateral defect, de novo cystocele, de novo rectocele, dyspareunia, mesh erosion, relapse of apical prolapse and satisfaction rate.)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验